Meftria S 500mg/250mg Injection
Marketer
Mgee Healthcare
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Meftria S 500mg/250mg Injection
Combiflox 500mg/250mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be strictly under medical supervision; adherence to the prescribed schedule is crucial for optimal efficacy. Incomplete treatment may compromise its effectiveness. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects warrant immediate medical attention. Seek immediate help for allergic reactions (rash, pruritus, edema, dyspnea). Inform your physician of all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential additive drowsiness. While usually non-impairing, avoid driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration contribute to faster recovery. Your doctor may order blood tests and imaging to monitor treatment response.
Uses of Meftria S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Meftria S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Meftria S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Meftria S 500mg/250mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Meftria S 500mg/250mg Injection works:
The injectable formulation Meftria S (500mg Ceftriaxone/250mg Sulbactam) unites a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's antibacterial action stems from its disruption of bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam's role is to counteract bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Meftria S 500mg/250mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Meftria S (500mg/250mg) is typically deemed safe for use during gestation. Preclinical trials using animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
Administering Meftria S 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment course and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Meftria S 500mg/250mg Injection can lead to reduced alertness, visual impairment, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Meftria S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Exercise caution when administering Meftria S 500mg/250mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alterations for Meftria S 500mg/250mg Injection are not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Meftria S 500mg/250mg Injection :
Omit a scheduled Meftria S 500mg/250mg Injection? Seek medical advice immediately.
Facts to Know About Meftria S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently